These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1310033)

  • 1. Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution.
    de Vos AM; Ultsch MH; Kelley RF; Padmanabhan K; Tulinsky A; Westbrook ML; Kossiakoff AA
    Biochemistry; 1992 Jan; 31(1):270-9. PubMed ID: 1310033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH; Nieuwenbroek NM; Verheijen JH
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct identification of lysine-33 as the principal cationic center of the omega-amino acid binding site of the recombinant kringle 2 domain of tissue-type plasminogen activator.
    De Serrano VS; Sehl LC; Castellino FJ
    Arch Biochem Biophys; 1992 Jan; 292(1):206-12. PubMed ID: 1309292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the lysine-fibrin binding subsite of human plasminogen kringle 4.
    Mulichak AM; Tulinsky A
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):673-9. PubMed ID: 1966798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand binding to the tissue-type plasminogen activator kringle 2 domain: structural characterization by 1H-NMR.
    Byeon IJ; Kelley RF; Mulkerrin MG; An SS; Llinás M
    Biochemistry; 1995 Mar; 34(9):2739-50. PubMed ID: 7893685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
    Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
    J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of lysine and clot binding properties in the kringle one domain of tissue-type plasminogen activator.
    Bakker AH; van der Greef W; Rehberg EF; Marotti KR; Verheijen JH
    J Biol Chem; 1993 Sep; 268(25):18496-501. PubMed ID: 8395505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug.
    Byeon IJ; Llinás M
    J Mol Biol; 1991 Dec; 222(4):1035-51. PubMed ID: 1762144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with omega-amino acid ligands.
    De Serrano VS; Castellino FJ
    Biochemistry; 1993 Apr; 32(14):3540-8. PubMed ID: 8385482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1H NMR structural characterization of a recombinant kringle 2 domain from human tissue-type plasminogen activator.
    Byeon IJ; Kelley RF; Llinás M
    Biochemistry; 1989 Nov; 28(24):9350-60. PubMed ID: 2558718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kringle-kringle interactions in multimer kringle structures.
    Padmanabhan K; Wu TP; Ravichandran KG; Tulinsky A
    Protein Sci; 1994 Jun; 3(6):898-910. PubMed ID: 8069221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cationic locus on the recombinant kringle 2 domain of tissue-type plasminogen activator that stabilizes its interaction with omega-amino acids.
    De Serrano VS; Castellino FJ
    Biochemistry; 1992 Dec; 31(47):11698-706. PubMed ID: 1332768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal and molecular structure of human plasminogen kringle 4 refined at 1.9-A resolution.
    Mulichak AM; Tulinsky A; Ravichandran KG
    Biochemistry; 1991 Oct; 30(43):10576-88. PubMed ID: 1657148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-ligand interactions in the lysine-binding site of plasminogen kringle 4 are different in crystal and solution. Electrostatic interactions studied by site-directed mutagenesis exclude Lys35 as an important acceptor in solution.
    Nielsen PR; Einer-Jensen K; Holtet TL; Andersen BD; Poulsen FM; Thøgersen HC
    Biochemistry; 1993 Dec; 32(48):13019-25. PubMed ID: 8241155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamics of ligand binding and denaturation for His64 mutants of tissue plasminogen activator kringle-2 domain.
    Kelley RF; DeVos AM; Cleary S
    Proteins; 1991; 11(1):35-44. PubMed ID: 1961700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, purification, and characterization of the recombinant kringle 1 domain from tissue-type plasminogen activator.
    DeSerrano VS; Menhart N; Castellino FJ
    Arch Biochem Biophys; 1992 Apr; 294(1):282-90. PubMed ID: 1550352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
    Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
    Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kringle glycosylation in a modified human tissue plasminogen activator improves functional properties.
    Berg DT; Burck PJ; Berg DH; Grinnell BW
    Blood; 1993 Mar; 81(5):1312-22. PubMed ID: 8382971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide.
    Cockell CS; Marshall JM; Dawson KM; Cederholm-Williams SA; Ponting CP
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):99-105. PubMed ID: 9639568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete assignment of the aromatic proton magnetic resonance spectrum of the kringle 1 domain from human plasminogen: structure of the ligand-binding site.
    Motta A; Laursen RA; Llinás M; Tulinsky A; Park CH
    Biochemistry; 1987 Jun; 26(13):3827-36. PubMed ID: 2820478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.